KMKeyvan Moeini

Keyvan Moeini

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Keyvan Moeini has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A PYRIDYL-TRIAZINE COMPLEX OF Co(II): SPECTROSCOPIC, STRUCTURAL, AND DOCKING STUDIES

    by F. Marandi, K. Moeini, H. Krautscheid

    A new cobalt(II) complex of 5-phenyl-3-(pyridin-2-yl)-1,2,4-triazine (PPTA), [Co(PPTA)2(NO3)2] (1), is prepared and identified by the elemental analysis, FTIR spectroscopy, and single crystal X-ray diffraction. The single crystal X-ray diffraction analysis of 1 reveals an octahedrally coordinated cobalt(II) complex containing two chelating N2-donor PPTA and two O-donor nitrato ligands in trans-conformation. In addition to hydrogen bonds in the crystal network of 1, there are π–π stacking interactions between aromatic rings of the adjacent complex molecules (pyridine⋯pyridine and pyridine⋯triazine). The ability of complex 1 to interact with nine selected biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS, Top II) is investigated by docking studies. The results show that in many cases, the studied compound can interact with proteins better than doxorubicin.


  • Coordination of a triazine ligand with CuII and AgI investigated by spectral, structural, theoretical and docking studies

    by Farzin Marandi, Keyvan Moeini, Harald Krautscheid

    Two complexes of 5-phenyl-3-(pyridin-2-yl)-1,2,4-triazine (PPTA), namely (ethanol-κO)bis(nitrato-κO)[5-phenyl-3-(pyridin-2-yl-κN)-1,2,4-triazine-κN 2]copper(II), [Cu(NO3)2(C14H10N4)(C2H6O)] or [Cu(NO3)2(PPTA)(EtOH)] (1), and bis[μ-5-phenyl-3-(pyridin-2-yl)-1,2,4-triazine]-κ3 N 1:N 2,N 3;κ3 N 2,N 3:N 1-bis[(nitrato-κO)silver(I)], [Ag2(NO3)2(C14H10N4)2] or [Ag2(NO3)2(μ-PPTA)2] (2), were prepared and characterized by elemental analysis, FT–IR spectroscopy and single-crystal X-ray diffraction. The X-ray structure analysis of 1 revealed a copper complex with square-pyramdial geometry containing two O-donor nitrate ligands along with an N,N′-donor PPTA ligand and one O-donor ethanol ligand. In the binuclear structure of 2, formed by the bridging of two PPTA ligands, each Ag atom has an AgN3O environment and square-planar geometry. In addition to the four dative interactions, each Ag atom interacts with two O atoms of two nitrate ligands on adjacent complexes to complete a pseudo-octahedral geometry. Density functional theory (DFT) calculations revealed that the geometry around the Cu and Ag atoms in 1 opt and 2 opt (opt is optimized) for an isolated molecule is the same as the experimental results. In 1, O—H...O hydrogen bonds form R 1 2(4) motifs. In the crystal network of the complexes, in addition to the hydrogen bonds, there are π–π stacking interactions between the aromatic rings (phenyl, pyridine and triazine) of the ligands on adjacent complexes. The ability of the ligand and complexes 1 and 2 to interact with ten selected biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS, Top II and B-DNA) was investigated by docking studies. The results show that the studied compounds can interact with proteins better than doxorubicin (except for TrxR and Top II).


  • Spectral, structural and theoretical study of the effects of thiocyanato and dicyanamido ligands on the geometry of PbIIcomplexes containing a triazinic ligand

    by Farzin Marandi, Keyvan Moeini, Zahra Mardani, Harald Krautscheid

    Two lead(II) complexes of 5,6-bis(furan-2-yl)-3-(pyridin-2-yl)-1,2,4-triazine (DFPT), namely one-dimensional (1D)catena-poly[[bis[5,6-bis(furan-2-yl)-3-(pyridin-2-yl-κN)-1,2,4-triazine-κN2]lead(II)]-di-μ-thiocyanato-κ2N:S;κ2S:N], [Pb(NCS)2(C16H10N4O2)2]n,1, and binuclear di-μ-dicyanamido-κ2N1:N5;κ2N5:N1-bis{[5,6-bis(furan-2-yl)-3-(pyridin-2-yl-κN)-1,2,4-triazine-κN2](nitrato-κ2O,O′)lead(II)}, [Pb2(C2N3)2(NO3)2(C16H10N4O2)4],2, as well as DFPT itself, were prepared and identified by elemental analysis, FT–IR,1H NMR spectroscopy and single-crystal X-ray structural analyses. In the double-chain 1D coordination polymer of1and the binuclear structure of2, the Pb atom has ahemidirected-PbN6S2and a rareholodirected-PbN6O2environment, respectively, with a distorted cubic geometry. All the coordination modes of dicyanamide ligands within lead complexes were studied using the Cambridge Structural Database (CSD) to compare them with the structures of1and2. In addition to hydrogen bonds, the crystal networks are stabilized by π–π stacking interactions between the triazine, furyl and pyridine aromatic rings. The most stable theoretical structures of the title compounds predicted by density functional theory (DFT) calculations were compared with the solid-state results.


  • Reaction of 2-[(2-aminoethyl)amino]ethanol with pyridine-2-carbaldehyde and complexation of the products with CuII and CdII along with docking studies

    by Zahra Mardani, Mohammad Hakimi, Keyvan Moeini, Fabian Mohr

    The reaction between 2-[2-(aminoethyl)amino]ethanol and pyridine-2-carbaldehyde in a 1:2 molar ratio affords a mixture containing 2-({2-[(pyridin-2-ylmethylidene)amino]ethyl}amino)ethanol (PMAE) and 2-[2-(pyridin-2-yl)oxazolidin-3-yl]-N-(pyridin-2-ylmethylidene)ethanamine (POPME). Treatment of this mixture with copper(II) chloride or cadmium(II) chloride gave trichlorido[(2-hydroxyethyl)({2-[(pyridin-2-ylmethylidene)amino]ethyl})azanium]copper(II) monohydrate, [Cu(C10H16N3O)Cl3]·H2O or [Cu(HPMAE)Cl3]·H2O, 1, and dichlorido{2-[2-(pyridin-2-yl)oxazolidin-3-yl]-N-(pyridin-2-ylmethylidene)ethanamine}cadmium(II), [CdCl2(C16H18N4O)] or [CdCl2(POPME)], 2, which were characterized by elemental analysis, FT–IR, Raman and 1H NMR spectroscopy and single-crystal X-ray diffraction. PMAE is potentially a tetradentate N3O-donor ligand but coordinates to copper here as an N2 donor. In the structure of 1, the geometry around the Cu atom is distorted square pyramidal. In 2, the Cd atom has a distorted octahedral geometry. In addition to the hydrogen bonds, there are π–π stacking interactions between the pyridine rings in the crystal packing of 1 and 2. The ability of PMAE, POPME and 1 to interact with ten selected biomolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS, Top II and B-DNA) was investigated by docking studies and compared with doxorubicin.


  • Structural conversion of an oxazolidine ligand upon treatment with copper(I) and (II) halides; structural, spectral, theoretical and docking studies

    by Zahra Mardani, Vali Golsanamlou, Zahra Jabbarzadeh, Keyvan Moeini, Saba Khodavandegar, Cameron Carpenter-Warren, Alexandra M. Z. Slawin, J. Derek Woollins

    In this work, the 2-(2-(pyridin-2-yl)oxazolidin-3-yl)ethanol (AEPC) ligand was prepared under solvent free conditions using ultrasonic irradiation, before reaction with a Cu(NO3)2/KSCN mixture, CuCl2 and CuI, the products of which were characterized by elemental analysis, UV-Vis, FT-IR spectroscopy and single-crystal X-ray diffraction. The X-ray analyses results revealed that AEPC, after reactions with the three copper(I/II) halides, gave structures ([Cu(DEA)Cl2] (2), DEA = diethanolamine, [Cu(BHEG)2] (3), BHEG = bis(2-hydroxyethyl)glycinato), however it retains its structure on treatment with Cu(NO3)2/KSCN mixture ([Cu(AEPC)(NCS)2] (1)). The geometrical parameters for the complexes were compared with the Cambridge Structural Database (CSD) and coordination modes for thiocyanate ion were extracted. In the crystal structure of 1, the copper ion has a distorted square-pyramidal geometry and a CuNpyN2NCSNtertOalc environment in which the AEPC acts as NN'O-donor in a facial coordination mode. In the crystal structure of 2, the copper ion has a Cu(Nsec)(Oalc)2Cl2 environment and distorted square-pyramidal geometry in which the DEA ligand is coordinated as a mer-NO2-donor. The copper ion in 3 has a CuN2O4 environment and distorted octahedral geometry. The ability of these compounds to interact with the nine biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) was investigated by Docking calculations and compared with that of doxorubicin. The thermodynamic stability of 1 and its isomer and also charge distribution patterns were studied by DFT and NBO analysis, respectively.


  • Docking studies to evaluate the biological activities of the Co(II) and Ni(II) complexes containing the triazine unit: supported by structural, spectral, and theoretical studies

    by Farzin Marandi, Keyvan Moeini, Akbar Arkak, Zahra Mardani, Harald Krautscheid

    Two complexes of 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine (L), [Co(L)2(NO3)2] (1) and [Ni(L)2(NO3)2] (2), were prepared and identified along with L by elemental analysis, FT-IR, UV-Vis and 1H NMR spectroscopies and single-crystal X-ray diffraction. All coordination modes of the 1,2,4-triazine unit and also of the nitrato ligand in coordination with cobalt and nickel atoms were studied by analysis of the Cambridge Structural Database (CSD) to compare with the new results. X-ray structure analysis of complexes 1 and 2 revealed that the metal atom in both complexes has an octahedral geometry with MN4O2 environment (M: Co (1), Ni (2)). The ligand acts as a bidentate NtzNpy-donor and forms a five-membered planar chelate ring. In addition to the hydrogen bonds, the crystal network is stabilized by π–π stacking interactions between pyridine rings of the ligands of adjacent complexes. The thermodynamic stability of the two conformational isomers of the 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine and their charge distribution patterns were studied by DFT and NBO analysis, respectively. The ability of the uncoordinated ligand conformers and complexes 1 and 2 to interact with nine selected biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) was investigated by docking calculations and compared with that of doxorubicin. Also an analogue of the ligand in which the furyl rings are replaced by phenyl groups is included in these studies.


  • Spectral, Structural, Theoretical and Docking Studies of a Mn(II) Complex with an N4-Donor Ligand

    by Mohammad Hakimi, Behjat Tarani, Zahra Mardani, Keyvan Moeini, Monika Kučeráková, Michal Dušek

    The complex [Mn(EMMP)(OAc)2]·3H2O, [EMMP = N,N′-(ethane-1,2-diyl)bis(1-phenyl-1-{pyridin-2-yl}methanimine] has been prepared and has a distorted square-faced bicapped trigonal prismatic geometry. In the crystal network of the complex, the water molecules form stronger hydrogen bonds than the complex molecules and participate in the formation of R44(8) hydrogen bond motifs. The ability of the complex and its ligand to interact with the biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) has been investigated by docking calculations and compared with that of doxorubicin.


  • Structural, spectral and theoretical study of the coordination of 3,6-bis(2-pyridyl)tetrazine ligand with zinc(II) and mercury(II)

    by Lotfali Saghatforoush, Keyvan Moeini, Vali Golsanamlou, Vahid Amani, Akbar Bakhtiari, Zahra Mardani


  • Open Access

    Theoretical and experimental investigation of anticancer activities of an acyclic and symmetrical compartmental Schiff base ligand and its Co(ii), Cu(ii) and Zn(ii) complexes

    by Lotfali Saghatforoush, Keyvan Moeini, Seyed Abolfazl Hosseini-Yazdi, Zahra Mardani, Alireza Hajabbas-Farshchi, Heather T. Jameson, Shane G. Telfer, J. Derek Woollins

    A compartmental Schiff base ligand, 2,2′-((((((2-hydroxypropane-1,3-diyl)bis(oxy))bis(2,1-phenylene))bis(methylene))bis(azanylylidene))bis(methanylylidene))bis(4-bromophenol) (H3LBr) and its complexes with cobalt(II), copper(II) and zinc(II) including, [Co(HLBr)] (1), [Cu2(LBr)(μ-1,3-OAc)]·MeOH (2) and [Zn(HLBr)] (3) were prepared using template synthesis and characterised by elemental analysis, FT-IR and 1H NMR spectroscopies and single-crystal X-ray diffraction. In the structure of complexes 1 and 3 the metal atom has a MN2O2 environment with tetrahedral geometry while complex 2 has a binuclear structure with a MNO4 environment and square planar geometry around the copper atom. The ability of all compounds to interact with the nine biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS and Top II) are investigated by docking calculations. For examination of the docking results, the in vitro activities of eight compounds against the human leukemia cell line K562 was investigated by evaluation of IC50 values and mode of cell death (apoptosis).